Medicine and Dentistry
Cystectomy
100%
Prostate Cancer
87%
Partial Nephrectomy
75%
Bladder Cancer
68%
Neoplasm
54%
Bladder
54%
Prostatectomy
52%
Combination Therapy
50%
Robot-Assisted Prostatectomy
50%
Gleason Score
50%
Transitional Cell Carcinoma
50%
Malignant Neoplasm
41%
Prostate Biopsy
38%
Morphine
38%
Overall Survival
37%
Ureteroscopy
37%
Transurethral Resection
37%
Kidney Cancer
35%
Recurrent Disease
32%
Biochemical Recurrence
32%
Meta-Analysis
31%
Pelvis
27%
Breath Analysis
25%
Pubovaginal Sling Procedure
25%
Pentane
25%
Selected-Ion Flow-Tube Mass Spectrometry
25%
Surgeon
25%
Sex Difference
25%
Stress Incontinence
25%
Surgical Technique
25%
Urinary Diversion
25%
Urologic Oncology
25%
6 Diazo 5 Oxonorleucine
25%
Tumor Biopsy
25%
Antibiotic Prophylaxis
25%
Transplantation
25%
Ablation Therapy
25%
Kidney Stone
25%
Radical Surgery
25%
Procedural Pain
25%
Telemedicine
25%
Clear Cell Renal Cell Carcinoma
25%
Diet Therapy
25%
Urinary Tract Carcinoma
25%
Kidney Allograft
25%
Transurethral Electrovaporization
25%
Prostate Hypertrophy
25%
Solitary Kidney
25%
Upper Urinary Tract
25%
Biopsy Technique
25%
Keyphrases
Robot-assisted Radical Cystectomy
85%
Upper Tract Urothelial Carcinoma
75%
Prostate Cancer
63%
Radical Cystectomy
59%
Overall Survival
54%
Opioids
50%
Medical Therapy
50%
Robot-assisted Radical Prostatectomy
50%
Robotic Partial Nephrectomy
50%
Reporting System
50%
Bladder
50%
Bladder Cancer
40%
Confidence Interval
38%
Opioid Prescription
38%
Open Radical Cystectomy
35%
Transurethral Resection of Prostate
33%
Retrospective Analysis
33%
Ureteroscopy
33%
National Cancer Database
31%
Readmission
30%
Pathological Downstaging
28%
Clinically Localized
28%
Genetic Differences
28%
Area under the Curve
28%
Morphine Milligram Equivalents
28%
Tumor
27%
Postoperative Outcomes
26%
Functional Outcome
26%
Positive Surgical Margin
25%
Novel Endpoints
25%
United States
25%
Total Intravenous
25%
Allograft Kidney
25%
Prescribing Rates
25%
Phoenix
25%
PT3a
25%
Risk Factors
25%
Pathologic
25%
Brachytherapy Seeds
25%
SIFT-MS
25%
Exhaled Breath Analysis
25%
Benign Prostatic Hyperplasia
25%
Pentane
25%
Stone Prevention
25%
Autologous Fascial Sling
25%
Genitourinary Cancer
25%
Neoadjuvant Chemotherapy
25%
Prognostic Implications
25%
Upper Urinary Tract Carcinoma
25%
Partial Nephrectomy
25%